Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy
2020 · Frontiers in Oncology · 155 citations
https://doi.org/10.3389/fonc.2020.01510
H
Hongyu Qi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
864
Citations
16
h-index
20
i10-index
Hongyu Qi is an academic researcher from Changchun University of Chinese Medicine. The author has contributed to research in topics: Ginseng Biological Effects and Applications & Sperm and Testicular Function & Reproductive biology and impacts on aquatic species. The author has an h-index of 16, co-authored 32 publications.
ORCID: 0000-0002-3217-9928Papers by this author
worksPanax ginseng clinical trials: Current status and future perspectives
2020 · Biomedicine & Pharmacotherapy · 49 citations
https://doi.org/10.1016/j.biopha.2020.110832
Ginsenoside compound K protects against cerebral ischemia/reperfusion injury via Mul1/Mfn2-mediated mitochondrial dynamics and bioenergy
2022 · Journal of Ginseng Research · 35 citations
https://doi.org/10.1016/j.jgr.2022.10.004
Comparisons of Isolation Methods, Structural Features, and Bioactivities of the Polysaccharides from Three Common Panax Species: A Review of Recent Progress
2021 · Molecules · 33 citations
https://doi.org/10.3390/molecules26164997
The protective effects of baicalin for respiratory diseases: an update and future perspectives
2023 · Frontiers in Pharmacology · 22 citations
https://doi.org/10.3389/fphar.2023.1129817
Recent advances in ginsenosides against respiratory diseases: Therapeutic targets and potential mechanisms
2022 · Biomedicine & Pharmacotherapy · 20 citations
https://doi.org/10.1016/j.biopha.2022.114096
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat